Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2018201920202021
Revenues<1m<1m1.3m<1m
% growth-513 %331 %(94 %)
EBITDA(<1m)<1m27.0m(<1m)
% EBITDA margin(545 %)8 %2084 %(143 %)
Profit(<1m)-21.3m<1m
% profit margin(571 %)-1647 %955 %

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$1.0m

Early VC

N/A

Grant

€480k

Grant

SEK425m

Acquisition
Total Funding€1.4m

Recent News about CARTANA

Edit
More about CARTANAinfo icon
Edit

Cartana, a pioneering company in the field of spatial genomics, provides cutting-edge solutions for advanced biological research and discovery. The company specializes in developing high-resolution spatial transcriptomics technology, which allows researchers to visualize gene expression in tissue samples with unprecedented detail. This technology is crucial for understanding complex biological systems and diseases at the molecular level. Cartana serves a diverse range of clients, including academic institutions, pharmaceutical companies, and biotechnology firms, operating primarily in the life sciences market. The business model revolves around the sale of its proprietary reagents and kits, as well as offering specialized services and support to its clients. Revenue is generated through direct sales, partnerships, and collaborations with leading research institutions and companies.

Keywords: spatial genomics, transcriptomics, biological research, gene expression, tissue samples, molecular level, life sciences, reagents, biotechnology, pharmaceutical.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.